Ad is loading...
GFAFX
Price
$80.89
Change
+$0.46 (+0.57%)
Updated
Nov 22 closing price
LGLVX
Price
$50.74
Change
-$0.05 (-0.10%)
Updated
Nov 22 closing price
Ad is loading...

GFAFX vs LGLVX

Header iconGFAFX vs LGLVX Comparison
Open Charts GFAFX vs LGLVXBanner chart's image
American Funds Growth Fund of Amer F1
Price$80.89
Change+$0.46 (+0.57%)
VolumeN/A
CapitalizationN/A
Lord Abbett Growth Leaders R6
Price$50.74
Change-$0.05 (-0.10%)
VolumeN/A
CapitalizationN/A
GFAFX vs LGLVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFAFX vs. LGLVX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a StrongBuy and LGLVX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 302B vs. LGLVX (7.25B). GFAFX pays higher dividends than LGLVX: GFAFX (0.45) vs LGLVX (0.00). GFAFX was incepted earlier than LGLVX: GFAFX (24 years) vs LGLVX (9 years). LGLVX is a more actively managed with annual turnover of: 120.00 vs. GFAFX (31.00). LGLVX has a lower initial minimum investment than GFAFX: LGLVX (0) vs GFAFX (250). LGLVX annual gain was more profitable for investors over the last year : 52.33 vs. GFAFX (28.83). LGLVX return over 5 years is better than : 80.12 vs. GFAFX (56.09).
GFAFXLGLVXGFAFX / LGLVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years9 years-
Gain YTD29.19746.77562%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets302B7.25B4,167%
Annual Yield % from dividends0.450.00-
Returns for 1 year28.8352.3355%
Returns for 3 years0.3513.083%
Returns for 5 years56.0980.1270%
Returns for 10 years72.42N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTEN8.680.32
+3.83%
Patterson-UTI Energy
GHM44.651.30
+3.00%
Graham Corp
DOW45.460.65
+1.45%
Dow
LEXX2.09-0.07
-3.24%
Lexaria Bioscience Corp
SAVA26.48-5.70
-17.71%
Cassava Sciences